Missing link identified: GpBAR1 is a neuronal bile acid receptor

Neurogastroenterology and Motility

Volumn 22, Issue 7, 2010, Pages 711-717

  Keely, S J ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Bile acids; Enteric nervous system; Farnesoid X receptor; GpBAR1; Intestinal motor function

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLECYSTOKININ; CHOLIC ACID; DEOXYCHOLIC ACID; G PROTEIN BILE ACID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; LITHOCHOLIC ACID; MUCIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADIPOSE TISSUE; AUTONOMIC NERVOUS SYSTEM; BACTERIAL FLORA; BILE ACID BLOOD LEVEL; BILE ACID SYNTHESIS; CELL DEATH; CELL METABOLISM; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; CELL TRANSPORT; COLON; DEAMINATION; DIARRHEA; DIGESTION; ENDOCRINE GLAND; ENDOCRINE SYSTEM; EPIMERIZATION; FOOD INTAKE; GALLBLADDER; GALLBLADDER CONTRACTION; GASTROINTESTINAL TRACT; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNEURON; INTESTINAL DYSMOTILITY; INTESTINE; INTESTINE ABSORPTION; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSIT TIME; INTRAHEPATIC CHOLESTASIS; LARGE INTESTINE; LIPID ABSORPTION; LIPID METABOLISM; LIPOPHILICITY; LIVER; LIVER CELL; MENSTRUAL CYCLE; MYENTERIC PLEXUS; NONHUMAN; PERMEABILITY BARRIER; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMALL INTESTINE; SMALL INTESTINE ABSORPTION; TIGHT JUNCTION;

ANIMALS; BILE ACIDS AND SALTS; ENDOCRINE GLANDS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; MICE; MYOELECTRIC COMPLEX, MIGRATING; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED;

EID: 77953339910     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01528.x     Document Type: Review

References (47)

1. Fiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci 2009 30 : 570 580.
2. Wei J, Qiu DK, Ma X. Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease. J Dig Dis 2009 10 : 85 90.
3. Pardi DS, Loftus EV, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003 124 : 889 893.
4. Ramalho RM, Viana RJS, Low WC, Steer CJ, Rodrigues CMP. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. Trends Mol Med 2008 14 : 54 62.
5. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009 89 : 147 191.
6. Poole D, Godfrey C, Cattaruzza F et al. Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil 2010 (this issue).
7. Russell D. The enzymes, regulation and genetics of bile acid biosynthesis. Annu Rev Biochem 2003 72 : 137 174.
8. Mariangeles P, Oth M, Deferme S et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006 58 : 1079 1089.
9. Hamilton JP, Xie G, Raufman J-P et al. Human cecal bile acids: concentration and spectrum. Am J Physiol Gastrointest Liver Physiol 2007 293 : G256 63.
10. Gälman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 2005 129 : 1445 1453.
11. Pennington C, Ross P, Murison J, Bouchier I. Fluctuations of serum bile acid concentrations during the menstrual cycle. J Clin Pathol 1981 34 : 185 186.
12. Angelin B, Björkhem I. Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids. Gut 1977 18 : 606 609.
13. Schalm S, LaRusso N, Hofmann A, Hoffman N, van Berge-Henegouwen G, MG K. Diurnal serum levels of primary conjugated bile acids. Assessment by specific radioimmunoassays for conjugates of cholic and chenodeoxycholic acid. Gut 1978 19 : 1006 1014.
14. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009 15 : 2049 2066.
15. Keating N, Keely S. Bile acids in regulation of intestinal physiology. Curr Gastroenterol Rep 2009 11 : 375 382.
16. Westergaard H. Bile acid malabsorption. Curr Treat Options Gastroenterol 2007 10 : 28 33.
17. Keating N, Mroz MS, Scharl MM et al. Physiological concentrations of bile acids down-regulate agonist induced secretion in colonic epithelial cells. J Cell Mol Med 2009 13 : 2293 2303.
18. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999 11 : 141 161.
19. Penagini R, Spiller R, Misiewicz J, Frost P. Effect of ileal infusion of glycochenodeoxycholic acid on segmental transit, motility, and flow in the human jejunum and ileum. Gut 1989 30 : 609 617.
20. Ooteghem NAMV, Samsom M, Erpecum KJV, Berge-Henegouwen GPV. Effects of ileal bile salts on fasting small intestinal and gallbladder motility. Neurogastroenterol Motil 2002 14 : 527 533.
21. Amato A, Cinci L, Rotondo A et al. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors. Neurogastroenterol Motil 2010 22 : 664 71, e203.
22. Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol 2008 295 : G260 72.
23. Ohama T, Hori M, Ozaki H. Mechanism of abnormal intestinal motility in inflammatory bowel disease: how smooth muscle contraction is reduced? J Smooth Muscle Res 2007 43 : 43 54.
24. Wedlake L, A'Hern R, Russell D, Thomas K, Walters J, Andreyev H. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009 30 : 707 717.
25. Makishima M, Okamoto AY, Repa JJ et al. Identification of a nuclear receptor for bile acids. Science 1999 284 : 1362 1365.
26. Maruyama T, Miyamoto Y, Nakamura T et al. Identification of membrane-type receptor for bile acids (M-BAR). Biochem Biophys Res Commun 2002 298 : 714 719.
27. Wang Y, Chen W, Moore D, Huang W. FXR: a metabolic regulator and cell protector. Cell Res 2008 18 : 1087 1095.
28. Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y. FXR, a multipurpose nuclear receptor. Trends Biochem Sci 2006 31 : 572 580.
29. Keitel V, Kubitz R, Haussinger D. Endocrine and paracrine role of bile acids. World J Gastroenterol 2008 14 : 5620 5629.
30. Fiorucci S, Baldelli F. Farnesoid X receptor agonists in biliary tract disease. Curr Opin Gastroenterol 2009 25 : 252 259.
31. Tiwari A, Maiti P. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. Drug Discov Today 2009 14 : 523 530.
32. Thomas C, Auwerx J, Schoonjans K. Bile acids and the membrane bile acid receptor TGR5 - Connecting nutrition and metabolism. Thyroid 2008 18 : 167 174.
33. Thomas C, Gioiello A, Noriega L et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009 10 : 167 177.
34. Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005 329 : 386 390. (Pubitemid 40255465)
35. Hellström PM. GLP-1: broadening the incretin concept to involve gut motility. Regul Pept 2009 156 : 9 12.
36. Dawson PA, Lan T, Rao A. Bile acid transporters. J Lipid Res 2009 50 : 2340 2357.
37. Gareau M, Jury J, MacQueen G, Sherman P, Perdue M. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 2007 56 : 1522 1528.
38. Cherbut C, Ferre J, Corpet D, Ruckebusch Y, Delort-Laval J. Alterations of intestinal microflora by antibiotics. Effects on fecal excretion, transit time, and colonic motility in rats. Dig Dis Sci 1991 36 : 1729 1734.
39. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009 41 : 850 853.
40. Van Felius I, Akkermans L, bosscha K et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil 2003 15 : 267 276.
41. Bolt M, Stellaard F, Sitrin M, Paumgartner G. Serum unconjugated bile acids in patients with small bowel bacterial overgrowth. Clin Chim Acta 1989 181 : 87 101.
42. Karlström L, Cassuto J, Jodal M, Lundgren O. Involvement of the enteric nervous system in the intestinal secretion induced by sodium deoxycholate and sodium ricinoleate. Scand J Gastroenterol 1986 21 : 331 340.
43. Peregrin A, Ahlman H, Jodal M, Lundgren O. Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin. Br J Pharmacol 1999 127 : 887 894.
44. Mekjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest 1971 50 : 1569 1577.
45. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol 2010 8 : 159 165. e155.
46. Kirwan W, Smith A, Mitchell W, Falconer J, Eastwood M. Bile acids and colonic motility in the rabbit and the human. Gut 1975 16 : 894 902.
47. Taylor I, Basu P, Hammond P, Darby C, Flynn M. Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome. Gut 1980 21 : 843 847. (Pubitemid 11198905)